✦ LIBER ✦

A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine

✍ Scribed by Jeffrey R. Infante; Suzanne F. Jones; Johanna C. Bendell; F. Anthony Greco; Denise A. Yardley; Cassie M. Lane; David R. Spigel; John D. Hainsworth; Howard A. Burris III

Publisher: Springer
Year: 2011
Tongue: English
Weight: 219 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1674-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A dose finding and pharmacokinetic study

A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer

✍ Lorenzo Fornaro; G. Masi; S. Bursi; F. Loupakis; E. Vasile; A. Antonuzzo; S. Chi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 273 KB

A study of the pharmacokinetics and phar

A study of the pharmacokinetics and pharmacodynamics of nifedipine in combination with atenolol

✍ T. J. Fitzsimons; S. C. Norris; H. K. Adam; J. Ryan; J. McAinsh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB 👁 2 views

This double-blind randomized, crossover study was undertaken to determine the pharmacokinetic properties of nifedipine retard and atenolol when given separately, as a free or a fixed combination, compared with placebo in 15 healthy male volunteers. There was no difference between the three atenolol

Drug biotransformation interactions in m

Drug biotransformation interactions in man II: A pharmacokinetic study of the simultaneous conjugation of Benzoic and Salicylic Acids with Glycine

✍ Lewis P. Amsel; Gerhard Levy 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB

The major route of biotransformation of benzoic acid and salicylic acid in man is conjugation with glycine, resulting in the formation of hippuric acid and salicyluric acid, respectively. Both processes are capacity-limited in the usual dose range and approach a maximum rate following administration

A phase I clinical and pharmacokinetic s

A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer

✍ R. O’Connor; M. O’Leary; J. Ballot; C. D. Collins; P. Kinsella; D. E. Mager; R. 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 291 KB

Phase I and pharmacokinetic study of a s

Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors : The relation between pharmacokinetic property and toxicity

✍ Ruey-Long Hong; Yun-Long Tseng 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

## BACKGROUND. Compared with free drug, sterically stabilized liposomal drug has prolonged circulation time and, thereby, higher tumor selectivity and antitumor activity. The stability in plasma is an important consideration in the formulation of clinically useful liposomal drug. A Phase I study o

A study evaluating the efficacy and tole

A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis

✍ Bengt G. Sorbe; Anne-Marie Berglind; Håkan Andersson; Karin Boman; Thomas Högber 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

## BACKGROUND. Chemotherapy-induced emesis is one of the most disturbing side effects of cancer therapy. Control of acute emesis has improved substantially during recent years, but control of delayed emesis and nausea remains a challenging problem. The role of 5-HT3 receptor antagonists in the tre